Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

21.1%

4 terminated/withdrawn out of 19 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

58%

11 trials in Phase 3/4

Results Transparency

58%

7 of 12 completed trials have results

Key Signals

3 recruiting7 with results

Enrollment Performance

Analytics

N/A
6(35.3%)
Phase 4
6(35.3%)
Phase 3
5(29.4%)
17Total
N/A(6)
Phase 4(6)
Phase 3(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT07287826Phase 4Recruiting

Using a Steroid Mouthwash to Prevent Mouth Sores During Chemotherapy

Role: lead

NCT04726085Not ApplicableTerminated

Ibuprofen Versus Indomethacin Following Emergent Cerclage Placement

Role: lead

NCT04873050Phase 4Recruiting

Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

Role: lead

NCT06057805Not ApplicableTerminated

The PPCGMS Intervention After GDM Trial

Role: lead

NCT04948112Not ApplicableCompleted

Effectiveness of CGMS Vs. Self-monitoring Blood Glucose (SMBG) in Woman with Gestational Diabetes

Role: lead

NCT04256889Not ApplicableCompleted

Use Of Nfant(R) Technology Feeding System For Infants Less Than 30 Weeks GA

Role: lead

NCT05067075Not ApplicableCompleted

The CGMS in GDM Labor and Delivery Study

Role: lead

NCT04741204Phase 4Withdrawn

Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer

Role: lead

NCT03480022Phase 3Completed

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

Role: lead

NCT02635386Phase 3Completed

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Role: lead

NCT04047849Phase 4Recruiting

Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Role: lead

NCT04139694Not ApplicableWithdrawn

Improving Insulin Resistance in Gynecological Cancer Patients

Role: lead

NCT01234649Phase 3Completed

Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)

Role: lead

NCT02338193Phase 3Completed

Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM Women

Role: lead

NCT01856907Phase 4Completed

Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM

Role: lead

NCT02022007Phase 3Completed

Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose Homeostasis

Role: lead

NCT01360996Phase 4Completed

Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism

Role: lead

NCT00849849Completed

Comprehensive Postpartum Screening Strategies for Women With Gestational Diabetes Mellitus (GDM)

Role: lead

NCT00687479Completed

Insulin Action During Pregnancy in Woman at High Risk for Gestational Diabetes

Role: lead

All 19 trials loaded